Arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene rs4073259 polymorphism not associated with ischemic stroke in the Northeastern Chinese Han population☆  by Zhang, RuYou et al.
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Objective:  Although  recent  evidence  has  implicated  that  5-lipoxygenase  activating  protein  (ALOX5AP)
gene  is associated  with  ischemic  stroke  (IS)  risk,  the  underlying  molecular  mechanism  remains  to be
deﬁned.  This  study  aimed  to  investigate  the  role  of  ALOX5AP  rs4073259  in  ischemic  stroke  in a  North-
eastern  Chinese  Han  population.
Methods: A  total  of 501 IS  patients  and  497  healthy  controls  were  enrolled  for  polymerase  chain  reaction
(PCR)  and  ligase  detection  reaction  (LDR)  analysis  of ALOX5AP  rs4073259  single  nucleotide  polymorphism
(SNP).
Results:  There  were  no statistically  signiﬁcant  differences  in ALOX5AP  rs4073259  allele  and  genotype
frequencies  between  IS  or subtypes  of IS  and  controls.  There  was  no  signiﬁcant  difference  in geno-
type  and allele  frequencies  of  atherosclerosis  degree  between  ischemic  subjects  with  carotid  artery
plaque  or  absence.  However,  total  cholesterol  (TC),  low-density  lipoprotein  (LDL),  and high-density
lipoprotein  (HDL)  in women  patients  were  signiﬁcantly  higher  than those  in  men  (p  = 0.015,  0.000,
and  0.008,  respectively).  Total  homocysteine  (tHcy)  was  higher  in  men  patients  than  that  in  women
(p  =  0.021).
Conclusion: There  was  no statistically  signiﬁcant  association  of  ALOX5AP  rs4073259  SNP  with  ischemic
n  Chi
 201stroke  in  this northeaster
©
. Introduction
Ischemic stroke (IS) is one of the leading causes of death
nd adult disability in the world [1,2]. Accumulating evidence
as indicated that ischemic stroke is a complicated clinical syn-
rome with diverse etiologies, including genetic predisposition
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and environmental factors [3–5]. Recent studies have also shown
that inﬂammation plays an important role in pathogenesis of
atherosclerosis, which is the major pathological basis of ischemic
stroke and cardiovascular disease [6–11]. Leukotrienes (LTs) are the
key components in inﬂammatory reactions and secreted by various
types of inﬂammatory cells, which are also implicated in initiation
and progression of atherosclerosis [6,12,13]. 5-lipoxygenase acti-
vating protein (FLAP) and 5-lipoxygenase pathway (5-LO) are the
key factors involved in the leukotrienes production [14,15]. Follow-
ing Ca+-dependent cell activation, arachidonic acid is released from
the cell membrane phospholipids by cytosolic phospholipase A2 for
synthesis of 5-LO by FLAP [16]. During this process, arachidonate is
converted into a unstable intermediate LTA4 [17] and conjunction
of LTA4 with glutathione by LTC4 synthase forms LTC4. LTC4 is then
cleaved by gamma-glutamyl transpeptidase to LTD4, which is then
Open access under CC BY-NC-ND license.metabolized by a dipeptidase to LTE4 [18,19]. The main pathophysi-
ological effect of these cysteinyl-LTs includes leucocytes activation,
monocyte diapedesis across the endothelial barrier, and increasing
permeability of blood vessels [20].
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The role of FLAP and 5-LO in production of leukotrienes could
e involved in pathogenesis of atherosclerosis. So it is reasonable
nd interesting to investigate the association of FLAP and 5-LO
ith IS. DeCODE genetic group ﬁrst showed a single ALOX5AP hap-
otype consisted of four single nucleotide acids, termed Hap A,
ould increase risk of myocardial infarction and ischemic stroke by
early two folds in the Iceland population [21]. The same research
roup also found another haplotype, i.e., Hap B, was  closely asso-
iated with the incidence of myocardial infarction in individuals
rom United Kingdom [22]. In contrast, another study found that
LOX5AP polymorphism had no association with MRI-deﬁned brain
nfarcts [23]. However, there were only a few studies reporting
he association of ALOX5AP rs4073259 with IS [24,25]. Thus, in this
tudy we mainly focused on investigation of ALOX5AP rs4073259
ssociation with IS risk in a northeastern Chinese Heilongjiang
rovince Han population.
.  Subjects and methods
.1.  Subjects
A  total of 501 patients with unrelated IS of the northeastern
hinese Han population (331 males, 170 females) were included in
his study. These patients have lived in Heilongjiang province for
ore than 20 years and were enrolled in this study from the Depart-
ent of Neurology, The Second Hospital afﬁliated to Harbin Medical
niversity (Harbin, Heilongjiang, China) between April 2011 and
ay  2012. All patients underwent the computed tomography (CT),
agnetic resonance imaging (MRI), or both in the head within
ne week after hospital admission. Among these 501 patients,
10 patients underwent magnetic resonance angiography (MRA)
r computed tomography angiography (CTA) to evaluate severity
f cerebral atherosclerosis. Eighty-seven patients received carotid
uplex sonography and showed there were two groups of patients,
.e., Group A was without carotid artery atherosclerosis plaque and
roup B was with carotid atherosclerosis plaque (e.g., hard plaque,
ombined plaques, and soft plaques). The patients undergone MRA
r CTA were divided into two groups, i.e., Group C was with intracra-
ial artery stenosis rate of ≤50% and Group D was  with intracranial
rtery stenosis rate of >50%. Transthoracal echocardiography was
btained in 150 patients.
According  to the criteria in the Trial of Org 10,172 in Acute Stroke
reatment (TOAST) classiﬁcation [26], these patients were further
lassiﬁed into ﬁve subgroups, i.e., large artery atherosclerosis, n = 81
16.2%); lacunar stroke, n = 310 (61.9%); large artery atherosclerosis
nd lacunar stroke (combination type), n = 104 (20.8%); cardiogenic
troke, n = 2 (0.4%); the etiology of stroke remained unclear despite
f different diagnostic efforts, n = 4 (0.8%). The subtype analysis was
imited to large artery atherosclerosis, lacunar stroke, and combi-
ation type because of small sample sizes of other subtypes.
Furthermore, we also recruited 497 healthy unrelated individ-
als as controls (300 males, 197 females) from Health Medical
enter, The Second Hospital afﬁliated to the Harbin Medical
niversity. All control subjects had no history of stroke, other
entral nervous system disorders, cardiovascular disease, cancer,
ndocrine diseases, infectious diseases, trauma, or surgery his-
ory. After neurological examination, there were no focal signs
etected in these control subjects. Among them, approximate 80
ubjects received brain CT scan and there were no positive disorders
etected.
A questionnaire was  designed to collect detailed informationbout risk factors of stroke, including gender, age, hypertension,
iabetes mellitus, hyperlipidemia, coronary heart disease, stroke
istory, arterial ﬁbrillation, smoking, and alcohol abusing for both
ases and controls. This study was approved by the local ethicsNeurosurgery 119 (2014) 64–69 65
committee  and each subject enrolled in this study was  informed
and consented.
2.2.  Genotyping
Peripheral venous blood was  withdrawn form each studied
subject for genotyping of ALOX5AP rs4073259 polymorphism,
which was performed by Shanghai BioWing Applied Biotech-
nology Company (http://www.biowing.com.cn) using a ligase
detection reaction (LDR) [27]. The primers used to the target
DNA sequence were 5′-CCAAAGGCTTCACCTCTGAT-3′ and 5′-
CGGCACATGAAAACAGCAC-3′. In brief, genomic DNA was  extracted
from EDTA blood using a standard protocol [28] and these
DNA samples were ampliﬁed by PCR in a 20 l reaction mix-
ture, which contained 1× PCR buffer, 0.6 l Mg++ (3.0 mmol/L),
50 ng of genomic DNA, 0.4 l each primer, 2 l deoxynucleotide
triphosphates (2.0 mmol/L), 0.3 l of 1U Qiagen HotStarTaq Poly-
merase (Qiagen, Germany) and 4 l of 1× Q-solution. The LDR
was performed in a 10 l reaction mixture containing 1× buffer,
12.5 pmol/l of each probe mix, 0.05 l of 2U Taq DNA ligase (New
England Biolabs, Ipswich, MA,  USA) and ≥1 l of 100 ng/l multi-
PCR product. Quality of the genotyping was  evaluated by testing
blind blood duplicates (49).
2.3. Statistics analysis
Allele  and genotype frequencies were calculated for each locus
and the Hardy–Weinberg equilibrium was  performed using the 2
test with SPSS 20.0 for windows software (SPSS, Chicago, IL, USA).
The association between phenotype and genotype was analyzed by
the 2 test. Logistic regression was  used to adjust the bias of classic
stroke risk factors, such as age, BMI, blood pressure, plasma glucose
level, lipid proﬁle, cigarette smoking, and alcohol intake. A p-value
of less than 0.05 was considered to be statistically signiﬁcant.
3.  Results
3.1. Characteristics of subjects
The clinical characteristics for the 501 IS patients and 497
healthy control subjects used in this study are shown in Table 1.
Particularly, there were signiﬁcant differences observed between
the IS and control group for age, BMI, SBP, DBP, hypertension, DM,
lipids, smoking, and alcohol consumption.
3.2. Genotype and allele frequencies
The characteristics of allele frequency and genotype frequency
were determined for rs4073259 in ALOX5AP promoter region and
the results was  summarized in Table 2. In brief, the A allele was
shown at a frequency of 53.6% in cases vs. 54.7% in controls. The G
allele was  found at a frequency of 46.4% in cases vs. 45.3% in con-
trols. There was  no statistically signiﬁcant difference in genotype
and allele frequencies between patients and controls. Using logis-
tics regression analysis to adjust the bias of conventional stroke
risk factors, there was also no association between the case and
control (p = 0.834 and 0.999, respectively). The allele and geno-
type frequencies of ALOX5AP rs4073259 did not signiﬁcantly differ
between the case and control using Hardy–Weinberg equilibrium
analysis (p = 0.237).
3.3. Subtype analysis of ISThe subtype analysis of IS was  performed using the groups of
large artery atherosclerosis, lacunar stroke and combination type.
A summary of the characteristics of allele frequency and genotype
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Table  1
Clinical characteristics of ischemic stroke patients and healthy controls
(mean  ± standard deviation).
Controls (n = 497) Cases (n = 501) p-Value
Age, years 53.12 ± 8.60 58.69 ± 10.17 0.000
Men, n (%) 300 (60.4) 331 (66.07) 0.062
BMI, kg/m2 23.39 ± 3.28 24.811 ± 3.33 0.000
SBP, mm Hg 115.64 ± 11.49 148.22 ± 23.46 0.000
DBP, mm Hg 78.85 ± 6.46 89.62 ± 13.45 0.000
Glucose, mmol/L 5.13 ± 2.04 6.8026 ± 3.10 0.000
TC, mmol/L 4.41 ± 0.51 5.3082 ± 3.39 0.000
TG, mmol/L 0.99 ± 0.31 1.8884 ± 1.47 0.000
HDL, mmol/L 1.47 ± 0.27 1.2783 ± 0.46 0.000
LDL, mmol/L 2.67 ± 0.45 2.8770 ± 0.82 0.000
ApoA, g/L 1.10 ± 0.214
ApoB, g/L 0.81 ± 0.24
Lip, ml/L 2.14 ± 0.45
tHcy, ml/L 18.64 ± 9.17
Cigarette smoker, n (%) 121 (24.35) 245 (48.90) 0.000
Alcohol intake, n (%) 134 (26.96) 191 (38.12) 0.000
Hypertension, n (%) 0 (0) 334 (66.67)
Diabetes, n (%) 0 (0) 113 (22.55)
Cardiopathy, n (%) 0 (0) 68 (13.57)
Notes: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood
pressure; TC, total cholesterol; TG, triglycerides; HDL, high-density lipopro-
tein  cholesterol; LDL, low density lipoprotein; ApoA, apolipoprotein A; ApoB,
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Table 4
Association of ALOX5AP rs4073259 between patients with or without carotid artery
atherosclerosis plaque.
Group A Group B p-Value
AA 5 (5.7) 22 (25.3)
AG 6 (6.9) 29 (33.3)
GG 4 (4.6) 21 (24.1) 0.971
A allele frequency 9.2 8.0
G allele frequency 42.0 40.8 0.793
Group A was without carotid artery atherosclerosis plaque, whereas Group B had
carotid atherosclerosis plaque (including hard plaque, combined plaques, and soft
plaques).
Table 5
Association of ALOX5AP rs4073259 between Group C and D patients.
Group C Group D p-Value
AA 35 (16.7) 27 (12.9)
AG  58 (27.6) 40 (19.0)
GG  28 (13.3) 22 (10.5) 0.911
A allele frequency 30.5 22.4
G  allele frequency 27.1 20.0 0.986
were classiﬁed as low, normal, and high according to the previously
T
A
T
Apolipoprotein B; Lip, lipoprotein a; tHcy, total homocystein.
requency in subtypes of IS are shown in Table 3. In particular, the A
llele was found at a frequency of 53.7% in large artery atheroscle-
osis, 54.0% in lacunar stroke, and 52.4% in combination type. The G
llele was found at a frequency of 46.3% in large artery atheroscle-
osis, 46.0% in lacunar stroke, and 48.6% in combination type. There
as no statistically signiﬁcant difference in genotype and allele
requencies among these IS subtypes.
.4. Association of stroke patients with carotid artery
therosclerosis plaque
We  also evaluated the association of ALOX5AP rs4073259 SNP
ith existence of carotid artery atherosclerosis plaque in ischemic
ubjects (Table 4). No signiﬁcant associations were observed for the
enotype and allele frequencies between ischemic subjects with
arotid artery atherosclerosis plaque (p = 0.971 and 0.793, respec-
ively).
able 2
LOX5AP rs4073259 allele and genotype frequencies between case and control.
rs4073259 Allele (%) p1 p1a Genotype, n 
A G AA 
Case 53.6 46.4 147 
Control 54.7 45.3 0.611 0.999 155 (31.2) 
a Adjusted by age, sex, BMI, SBP, DBP, Glu, TC, TG, LDL, HDL, hypertension, diabetes, tob
able 3
LOX5AP rs4073259 allele and genotype frequencies in IS subtypes.
rs4073259 Allele (%) p1
A 
Control (n = 497) 54.7 
Atherothrombosis (n = 81) 53.7 0.799 
Lacunar  (n = 310) 54.0 0.829 
Combination  (n = 104) 52.4 0.456 Group C patients had ≤50% of an intracranial artery stenosis rate, whereas Group D
patients had more than 50% of an intracranial artery stenosis rate.
3.5. Association of stroke patients with different severity of
atherosclerosis
MRA  or CTA were utilized as a tool to evaluate severity of cere-
bral atherosclerosis. Based on the established grading system, we
divided 210 IS patients who underwent MRA  or CTA into two sub-
groups, i.e., Group C patients had ≤50% of an intracranial artery
stenosis rate, whereas Group D patients had >50% of an intracra-
nial artery stenosis rate. The frequencies of ALOX5AP G/A genotype
or allele of rs4073259 had not difference between these two groups
of patients (p = 0.911 and 0.986, respectively; Table 5).
3.6. Association of genotype and lipid proﬁle of patients
We  then associated ALOX5AP genotypes with lipid proﬁles of
these 501 ischemic stroke patients and analyzed the lipid proﬁles
between male and female patients. The lipid proﬁles of the patientsdeﬁned normal range (TC, 3.8–5.17 mmol/L; TG, 0.56–1.70 mmol/L;
LDL, 0.45–3.15 mmol/L; HDL, 1.04–1.70 mmol/L; ApoA, 1.0–1.6 g/L;
(%) p2 p2a H-W p3
AG GG
243 (48.5) 111 (22.2)
234 (47.1) 108 (21.7) 0.816 0.834 0.237
acco smoking, and alcohol consumption.
Genotype, n (%) p2
AA AG GG
155(31.2) 234(47.1) 108(21.7)
22 (27.2) 43 (53.1) 16 (19.8) 0.601
94 (30.3) 147 (47.4) 69 (22.3) 0.963
28 (26.92) 51 (49.04) 25 (24.04) 0.674
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Table  6
Association of ALOX5AP rs4073259 polymorphism with lipid proﬁle in IS patients.
rs4073259 A/G Sex
AA AG GG p1 Male Female p2
TC
Low 19 (4.0) 21 (4.4) 11 (2.3) 0.711 36 (7.6) 15 (3.2) 0.015
Normal  56 (11.8) 99 (20.8) 48 (10.1) 148 (31.1) 55 (11.6)
High 68 (14.3) 107 (22.5) 47 (9.9) 133 (27.9) 89 (18.7)
TG
Low 3 (0.6) 4 (0.8) 1 (0.2) 0.939 5 (1.1) 3 (0.6) 0.671
Normal  77 (16.2) 128 (26.9) 61 (12.8) 173 (36.3) 93 (19.5)
High 63 (13.2) 95 (20) 44 (9.2) 139 (29.2) 63 (13.2)
HDL
Low 36 (7.6) 56 (11.8) 27 (5.7) 0.421 93 (19.5) 26 (5.4) 0.008
Normal  100 (21.0) 147 (30.9) 71 (14.9) 199 (41.8) 119 (25.0)
High 7 (1.5) 24 (5.0) 8 (1.7) 25 (5.3) 14 (2.9)
LDL
Normal 88 (18.5) 155 (32.6) 80 (16.8) 0.065 232 (48.7) 91 (19.1) 0.000
High  55 (11.6) 72 (15.1) 26 (5.5) 85 (17.9) 68 (14.3)
ApoA
Low 49 (10.9) 83 (18.4) 34 (7.5) 0.253 118 (26.2) 48 (10.6) 0.139
Normal  83 (18.4) 130 (28.8) 67 (14.9) 179 (39.7) 101 (22.4)
High 0 (0) 2 (0.4) 3 (0.7) 2 (0.4) 3 (0.7)
Apo B
Low  20 (4.4) 36 (8.0) 15 (3.3) 0.712 46 (10.2) 25 (5.5) 0.111
Normal  95 (21.1) 161 (35.7) 77 (17.1) 228 (50.6) 105 (23.3)
High 17 (3.8) 18 (4.0) 12 (2.7) 25 (5.5) 22 (4.9)
Lip
Low 41 (9.1) 57 (12.7) 29 (6.4) 0.853 90 (20.0) 37 (8.2) 0.171
Normal  89 (19.8) 151 (33.6) 72 (16.0) 203 (45.1) 109 (24.2)
High 2 (0.4) 6 (1.3) 3 (0.7) 5 (1.1) 6 (1.3)
tHcy
Normal 38 (12.5) 72 (23.7) 36 (11.8) 0.834 88 (28.9) 58 (19.1) 0.021
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alues are expressed as total number and percentage in the parentheses.
poB, 0.6–1.1 g/L; Lip, 1.9–3.2 ml/L; and total homocysteine,
.08–15.39 ml/L).
ALOX5AP rs4073259 polymorphism was  not associated
ith total cholesterol (p = 0.711), Triglycerides (p = 0.939), HDL
p = 0.421), LDL cholesterol (p = 0.065), Apolipoprotein A (p = 0.253),
poB (p = 0.712), Lip (p = 0.853), and tHcy (p = 0.834). TG, ApoA,
poB, and Lip were not different between male and female patients
p = 0.671, 0.139, 0.111, and 0.171, respectively). However, TC, LDL,
DL and tHcy were different between male and female patients,
.e., TC, LDL and HDL were signiﬁcantly higher in female patients
han in male patients (p = 0.015, 0.000, and 0.008, relatively), while
Hcy was higher in male patients than that in female patients
p = 0.021; Table 6).
.  Discussion
In this study, we investigated the association between ALOX5AP
s4073259 polymorphism and IS susceptibility. However, we did
ot ﬁnd a statistical difference in gender distribution between the
ase and the control, although the proportion of male patients
n the case group (60.4%) is higher than that of women  patients
39.6%). The median age, body mass index (BMI), blood lipids, glu-
ose, and blood pressure levels, tobacco, and alcohol consumption
ere higher than those in the controls, which is consistent with
he epidemiological ﬁndings. A previous study demonstrated that
any factors were contributed to IS and intracerebral haemor-
hagic stroke; for example, history of hypertension, current smoker,
aist-to-hip ratio, diet risk score, physical activity, diabetes mel-
itus, alcohol intake, psychosocial stress and depression, cardiac
lteration, and ratio of apolipoproteins B to A1 [4]. Furthermore,
here was no statistical association of ALOX5AP allele and geno-
ype frequencies between case or IS subtype and controls after a
ultivariate logistic regression analysis. After adjusting the bias of
lassical stroke risk factors, the results revealed that G/A genotype115 (37.8) 43 (14.1)
of ALOX5AP rs4073259 did not contribute to IS risk. There was no
statistically signiﬁcant difference in ALOX5AP genotype and allele
frequencies between the IS subtype and controls.
However, two  previous studies of different ethnic patients
showed that ALOX5AP rs4073259 was  associated with risk of IS
[24,25], i.e., Lohmussaar et al. [24] showed that there was a stronger
association of ALOX5AP rs4073259 between IS in male patients than
that in female patients in Iceland population (odds ratio, 1.26; 95%
CI 1.03–1.54; p = 0.024). Zhang et al. [25] analyzed ALOX5AP poly-
morphism in 236 patients with a history of cerebral infarction and
219 healthy subjects without a history of cerebral infarction or car-
diovascular disease and family history of cerebrovascular diseases
for three generations, which included individuals in the Han popu-
lation whose families have lived in the Northeastern part of China,
including Heilongjiang, Jilin, and Liaoning, for more than three
generations. They found that ALOX5AP rs4073259 A allele was asso-
ciated with an increased risk of ischemic stroke, whereas ALOX5AP
rs4073259 GG was associated with a decreased risk. In addition, Ji
et al. [29] showed that ALOX5AP promoter region-581 582 Ins A, an
insertion and deletion polymorphism, was a novel genetic variant
for ischemic stroke risk. Furthermore, a haplotype-based analysis
for ALOX5AP haplotype AA of block 2 involving rs10507391 and
rs12429692, and rs9579646 AG genotype was  associated with a
decreased risk of stroke in Eastern Chinese Han population [30].
However, in this study, we  did not ﬁnd any association of ALOX5AP
rs4073259 between the case and control. We also did not observe
the association of A allele with the increased risk of ischemic stroke
in the Han population, which lived in Heilongjiang province more
than 20 years. Our data failed to replicate all of these previous
ﬁndings. The underlying reason is unknown, but might be due to
different populations, sampling strategies, or phenotype hetero-
geneity. Another possibility is that etiologies of stroke in this study
and previous studies might have been different. For example, in this
study, IS patients with lacunar infarction had highest proportion
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61.9%), while IS incidence with unknown etiologies was lowest
0.8%). The latter was much lower than that reported in the litera-
ure [31], but it was consistent with another Chinese study reported
y Wu et al. [32]. However, the discrepancy of the rates between
hinese and other ethnic population remains unknown, which may
ead to a future collaborative study on this. Furthermore, although
0 subjects of our healthy controls without cerebrovascular dis-
ases who underwent brain CT scan did not show any positive
ndings, we could not ensure that brain CT scan without positive
nding in all of these healthy controls, thus, silent strokes cannot be
uled out. We  speculate that environmental factors may  contribute
o expression and activity of ALOX5AP. Heilongjiang is localized
t a high latitude area where residents grow accustom to high salt
nd fat diets, which are risk factors for hypertension and promote a
acunar stroke. In addition, detection of a single gene polymorphism
ould only associate with a modest effect, but multiple SNPs in mul-
iple genes plus a haplotype analysis may  have more powerful to
ssociate with IS risk.
Furthermore,  this study further explored the association of
arotid plaques and degree of cerebral atherosclerosis with
LOX5AP rs4073259 polymorphism. We  found that the G/A geno-
ype of rs4073259 was not a risk factor in developing atheroscle-
osis in ischemic subjects. Jin et al. [33] showed that frequency
f SG13S114 AA genotype and A allele was signiﬁcantly higher
n atherothrombotic cerebral infarction patients with vulnerable
laques than those with stable plaques; thus, and they deduced
hat A allele may  be a risk factor of vulnerable plaques. However, in
his study, we did not ﬁnd that ALOX5AP rs4073259 associated with
arotid artery atherosclerosis plaque. Based on the small number
f patients who underwent to carotid ultrasound examination and
erebral angiography, we cannot rule out contribution of ALOX5AP
s4073259 to atherosclerosis in ischemic stroke patients.
It  has been reported that various gene polymorphisms affect
ipids and tHcy proﬁle, although a previous study by Shin et al.
34] showed that there was no association between PON gene poly-
orphisms and stroke, but PON1-55 L allele elevated the plasma
oncentration of total homocysteine, PON2-148A and 311 S alleles
ere associated with higher plasma total and LDL cholesterol, and
poB, PON2-148G elevated plasma concentration of total and HDL
holesterol and ApoA1. Another study showed that that the HindIII
olymorphism of LPL was associated with ischemic stroke and ele-
ated levels of plasma triglycerides and reduced HDL levels. This
ene polymorphism was associated with intracranial large artery
therosclerosis that is the most frequent subtype in Andhra Pradesh
35]. However, to date, there is no study reported the association
etween ALOX5AP polymorphism and lipids and tHcy proﬁle. In
ur study, there was no association of ALOX5AP genotypes with lipid
roﬁles or total homocysteine levels. But levels of TC, LDL, HDL, and
Hcy were obviously different in men  and women, indicating that
heir levels were inﬂuenced by sex, life-style, and other factors.
s reported previously, many factors signiﬁcantly increased risk
f hyperhomocysteinemia, such as increased age, male sex, fam-
ly history of stroke, in addition to deﬁciencies of serum folate and
itamin B12, and elevated serum creatinine [36]. So we speculated
hat ALOX5AP polymorphisms may  contribute little to lipids proﬁle
nd tHcy level relative to environmental factors in ischemic stroke
atients in our region.
Ischemic  stroke is a complex clinical syndrome with different
tiologies and risk factors. Our current data demonstrated that
LOX5AP rs4073259 was not associated with ischemic stroke
isk in the northeastern Chinese Han population although TC,
DL, HDL, and tHcy were obviously different in men  and women.
ndoubtedly, further studies of different ethnic populations with a
arger sample size and brain CT or MRI  scan in all the subjects will
rovide insightful information regarding this SNP for association
ith IS risk.
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